Literature DB >> 11001069

Thrombin signalling and protease-activated receptors.

S R Coughlin1.   

Abstract

How does the coagulation protease thrombin regulate cellular behaviour? The protease-activated receptors (PARs) provide one answer. In concert with the coagulation cascade, these receptors provide an elegant mechanism linking mechanical information in the form of tissue injury or vascular leakage to cellular responses. Roles for PARs are beginning to emerge in haemostasis and thrombosis, inflammation, and perhaps even blood vessel development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11001069     DOI: 10.1038/35025229

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  697 in total

1.  Contractile actions of proteinase-activated receptor-derived polypeptides in guinea-pig gastric and lung parenchymal strips: evidence for distinct receptor systems.

Authors:  M Saifeddine; B Al-Ani; S Sandhu; S J Wijesuriya; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor.

Authors:  M Riewald; W Ruf
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

3.  So what is critically lacking with coronary atherosclerotic plaques? Perhaps the antithrombotic control.

Authors:  T S Edgington
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

Review 4.  Argatroban.

Authors:  Sekar Kathiresan; Jin Shiomura; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2002-02       Impact factor: 2.300

5.  Gene expression profile of coronary artery cells treated with nonsteroidal anti-inflammatory drugs reveals off-target effects.

Authors:  Sanjeewani T Palayoor; Molykutty J-Aryankalayil; Adeola Y Makinde; David Cerna; Michael T Falduto; Scott R Magnuson; C Norman Coleman
Journal:  J Cardiovasc Pharmacol       Date:  2012-06       Impact factor: 3.105

Review 6.  Which antithrombin for whom? Identifying the patient population that benefits most from novel antithrombin agents.

Authors:  David A Burke; Haider J Warraich; Duane S Pinto
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

7.  Hydrocephalus after intraventricular hemorrhage: the role of thrombin.

Authors:  Feng Gao; Fuyi Liu; Zhi Chen; Ya Hua; Richard F Keep; Guohua Xi
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-11       Impact factor: 6.200

8.  The Molecular Mechanisms that Promote Edema After Intracerebral Hemorrhage.

Authors:  Daniel Bodmer; Kerry A Vaughan; Brad E Zacharia; Zachary L Hickman; E Sander Connolly
Journal:  Transl Stroke Res       Date:  2012-04-12       Impact factor: 6.829

9.  Thrombin-induced cerebral hemorrhage: role of protease-activated receptor-1.

Authors:  Yingying Cheng; Guohua Xi; Hang Jin; Richard F Keep; Jiachun Feng; Ya Hua
Journal:  Transl Stroke Res       Date:  2013-09-21       Impact factor: 6.829

10.  Up-regulation of proteinase-activated receptor 1 and increased contractile responses to thrombin after subarachnoid haemorrhage.

Authors:  Y Maeda; K Hirano; Y Kai; M Hirano; S O Suzuki; T Sasaki; H Kanaide
Journal:  Br J Pharmacol       Date:  2007-09-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.